510(k) device
Ablation-fit
R.a.w. S.r.l · Radiological Image Processing Software For Ablation Therapy Planning And Evaluation (QTZ, Class II) · First FDA decision Sep 12, 2023, newest Sep 12, 2023Liver disease and liver cancerTumor ablation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
14
Naming "Ablation-fit"
MAUDE reports
0
Brand "Ablation-fit", since 2015
PubMed studies
1
Mentioning "Ablation-fit"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Ablation-fit
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Ablation-fit510(k)
K222938 · Decided Sep 12, 2023 · 351 days after receipt
Device type: Radiological Image Processing Software For Ablation Therapy Planning And Evaluation (QTZ) · Radiology & Imaging
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Psychiatric Diagnostic Evaluation and Psychotherapy ServicesLocal determinationIn effectL33252First Coast Service Options, Inc.Updated Jun 19, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "Ablation-fit", any status and sponsor, newest update first.
Chinese University of Hong KongAcademic, hospital or other
NCT05443451 · 12 participants · Start Sep 8, 2022 · Primary completion Oct 5, 2023
Device: 3D-Ultrasound-Guided Transperineal Microwave needle ablation of BPH · For: Prostate Hyperplasia
Sites: Hong Kong, Hong Kong
- Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent GlioblastomasNot yet recruiting
Washington University School of MedicineAcademic, hospital or other
NCT07620548 · 99 participants (planned) · Start Nov 30, 2026 · Primary completion May 31, 2031
Device: NeuroBlate® Laser Ablation Laser Interstitial Thermal Therapy · For: Glioblastoma; Glioblastoma, IDH-wildtype; Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Sites: Rochester, Minnesota; St Louis, Missouri
Boston Scientific CorporationPublic (BSX)
NCT06170606 · 200 participants · Start Jun 28, 2024 · Primary completion May 20, 2026
Device: Boston Scientific Cardiac Cryoablation System · For: Paroxysmal Atrial Fibrillation
Sites: Gilbert, Arizona; Phoenix, Arizona; Tucson, Arizona · 11 sites in all
11 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Ablation-fit", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QTZ
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Ablation-fit"[tiab]. The summary above synthesizes these.
- Multicenter and inter-software evaluation of ablative margins after thermal ablation of colorectal liver metastases.
Laimer G, Verdonschot KHM, Kopf L, et al. · Eur Radiol · 2025Multicenter Study
Other devices of this type
Also filed under product code QTZ.
- myAblation Guide (VC10A)Siemens Healthcare GmbH · 510(k) 2026
- VisAble.IOTechsomed · 510(k) 2024
- HistoSonics® Planning ToolHistoSonics, Inc. · 510(k) 2026
- BioTraceIO Vision (V1.7)Techsomed Medical Technologies · 510(k) 2025
- Artemis, Artemis TPO, Artemis MXEigen · 510(k) 2023
- MIM-AblationMim Software, Inc. · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.